FLT3 and chronic myelogenous leukemia, BCR-ABL1 positive: The top pathways identified include ERK/MAPK (p-value = 2.51 × 10−13), FLT3 (p-value = 6.31 × 10−12) and JAK/STAT (p-value = 6.31 × 10−12) signaling pathways, all of which play significant roles in CML cell survival and apoptosis.